Literature DB >> 8770866

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

H C Rath1, H H Herfarth, J S Ikeda, W B Grenther, T E Hamm, E Balish, J D Taurog, R E Hammer, K H Wilson, R B Sartor.   

Abstract

Genetic and environmental factors are important in the pathogenesis of clinical and experimental chronic intestinal inflammation. We investigated the influence of normal luminal bacteria and several groups of selected bacterial strains on spontaneous gastrointestinal and systemic inflammation in HLA-B27 transgenic rats. Rats maintained germfree for 3-9 mo were compared with littermates conventionalized with specific pathogen-free bacteria. Subsequently, germfree transgenic rats were colonized with groups of five to eight bacteria that were either facultative or strictly anaerobic. Transgenic germfree rats had no gastroduodenitis, colitis, or arthritis, but developed epididymitis and dermatitis to the same degree as conventionalized rats. Colonic proinflammatory cytokine expression was increased in transgenic conventionalized rats but was undetectable in germfree and nontransgenic rats. Colitis progressively increased over the first 4 wk of bacterial exposure, then plateaued. Only transgenic rats colonized with defined bacterial cocktails which contained Bacteroides spp. had colitis and gastritis. Normal luminal bacteria predictably and uniformly induce chronic colonic, gastric and systemic inflammation in B27 transgenic F344 rats, but all bacterial species do not have equal activities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770866      PMCID: PMC507509          DOI: 10.1172/JCI118878

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Assessment of leukocyte involvement during ischemia and reperfusion of intestine.

Authors:  M B Grisham; J N Benoit; D N Granger
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Molecular cloning and expression of rat interleukin-1 alpha cDNA.

Authors:  T Nishida; N Nishino; M Takano; Y Sekiguchi; K Kawai; K Mizuno; S Nakai; Y Masui; Y Hirai
Journal:  J Biochem       Date:  1989-03       Impact factor: 3.387

3.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders.

Authors:  R E Hammer; S D Maika; J A Richardson; J P Tang; J D Taurog
Journal:  Cell       Date:  1990-11-30       Impact factor: 41.582

4.  Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats.

Authors:  A J Severijnen; R van Kleef; M P Hazenberg; J P van de Merwe
Journal:  J Rheumatol       Date:  1989-08       Impact factor: 4.666

5.  Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis.

Authors:  K Granfors; S Jalkanen; A A Lindberg; O Mäki-Ikola; R von Essen; R Lahesmaa-Rantala; H Isomäki; R Saario; W J Arnold; A Toivanen
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

6.  The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives.

Authors:  J P Van de Merwe; A M Schröder; F Wensinck; M P Hazenberg
Journal:  Scand J Gastroenterol       Date:  1988-11       Impact factor: 2.423

7.  Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

8.  Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth.

Authors:  S N Lichtman; J Keku; J H Schwab; R B Sartor
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury.

Authors:  R B Sartor; T M Bond; J H Schwab
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

10.  Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers.

Authors:  R E Esser; S A Stimpson; W J Cromartie; J H Schwab
Journal:  Arthritis Rheum       Date:  1985-12
View more
  230 in total

1.  Animal models of the spondyloarthropathies.

Authors:  M Breban; G Falgarone; H Blanchard; E Dernis-Labous; D Lamarque
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

2.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

Review 3.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 4.  Prevention of postoperative recurrence in Crohn's disease.

Authors:  G D'Haens
Journal:  Curr Gastroenterol Rep       Date:  1999-12

Review 5.  Probiotics and inflammatory bowel disease.

Authors:  Daisy Jonkers; Reinhold Stockbrügger
Journal:  J R Soc Med       Date:  2003-04       Impact factor: 5.344

6.  Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation.

Authors:  J Shao; R B Sartor; E Dial; L M Lichtenberger; W Schepp; D H Alpers
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

7.  Atherogenic diet causes lethal ileo-ceco-colitis in cyclooxygenase-2 deficient mice.

Authors:  James A Lin; Junji Watanabe; Nora Rozengurt; Ajay Narasimha; Martin G Martin; Jenny Wang; Jonathan Braun; Robert Langenbach; Srinivasa T Reddy
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-04-25       Impact factor: 3.072

8.  Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

Authors:  James P Moran; Jens Walter; Gerald W Tannock; Susan L Tonkonogy; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

9.  Dysbiosis in inflammatory bowel disease.

Authors:  C P Tamboli; C Neut; P Desreumaux; J F Colombel
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.